Abbott reports second-quarter 2022 results and raises full-year eps guidance

Sales growth of 10.1 percent; organic sales growth of 14.3 percent gaap diluted eps growth of 72.7 percent; adjusted diluted eps growth of 22.2 percent global covid-19 testing-related sales of $2.3 billion in the second quarter continues to strengthen portfolio with new product approvals abbott park, ill., july 20, 2022 /prnewswire/ -- abbott (nyse: abt) today announced financial results for the second quarter ended june 30, 2022.
ABT Ratings Summary
ABT Quant Ranking